Extended Endocrine Therapy: Is 5 Years Enough?

July 7, 2018By CancerSmarterBreast Cancer, Research, Treatments
Extended Endocrine Therapy: Is 5 Years Enough?

Extended Endocrine Therapy: Is 5 Years Enough? Extended Endocrine Therapy: Is 5 Years Enough? NBC ran a story on this in 2017 citing a New England Journal of Medicine study that asked Extended Endocrine Therapy: Is 5 Years Enough? found extending therapy extends protection from recurrence. Breast cancer survivors will want to discuss these new findings with their doctors. The … Read More

FDA Approves First Treatment for Breast Cancer With a Certain Inherited Genetic Mutation

January 22, 2018By CancerSmarterBreast Cancer, Cancer Research, Treatments
FDA Approves First Treatment for Breast Cancer With a Certain Inherited Genetic Mutation

FDA Approves First Treatment for Breast Cancer With a Certain Inherited Genetic Mutation This is a major breakthrough for women with this inherited genetic mutation. It is the first time a drug has been developed to treat women with metastatic breast cancer who have a “BRCA” gene mutation. Richard Pazdur, M.D., director of the FDA’s Oncology … Read More